TOKYO, November 6, 2025 – FUJIFILM Holdings Corporation announced today its financial results for the first half, which ended September 30, 2025. In the first half of the fiscal year ending March 2026, revenue increased across all segments, achieving a 3.8% year-over-year increase to JPY1,572.4 billion. Operating income also rose across all segments, with the Imaging segment making a significant contribution, achieving a 16.9% year-over-year increase to JPY158.5 billion. Net income attributable to FUJIFILM Holdings increased by 9.0% year-over-year to JPY120.2 billion.
Considering the strong performance of the Imaging segment, the company has revised its consolidated full-year revenue forecast for the fiscal year ending March 2026 upward by JPY20.0 billion. The forecasted revenue is JPY3.30 trillion, with operating income of JPY331.0 billion, and net income attributable to FUJIFILM Holdings of JPY262.0 billion, aiming to achieve record highs. The annual dividend forecast for the fiscal year is JPY70 per share, marking the 16th consecutive annual dividend increase.
“In the first half of this financial year, we delivered record-high revenue and operating income across all business segments,” says Teiichi Goto, president and chief executive officer, representative director, FUJIFILM Holdings Corporation. “This exceptional performance reflects the continued strength of our Imaging business and the solid expansion of our growth drivers, including Healthcare and Semiconductor Materials. These strategic areas are steadily increasing their contribution to our overall results, and we remain firmly committed to driving sustainable growth and enhancing corporate value.”
- Revenue increased 8.7% year-over-year to JPY270.7 billion and operating income amounted to JPY19.4 billion, a slight decrease of 0.5% from the previous year.
- In the Medical Systems business, revenue growth was driven by strong sales of endoscopes, ultrasound, IVD (In-Vitro Diagnostics) products and medical IT products and services.
- In the Bio CDMO business, revenue increased due to contribution of the new facility in Denmark.
- Revenue in the Life Sciences Solutions business slightly increased supported by the recovery in the cell culture media market.
- Revenue increased 4.7% year-over-year to JPY107.3 billion and operating income increased 3.2% year-over-year to JPY19.4 billion.
- In the Electronic Materials business, revenue increased by 11.9% year-over-year, driven by strong demand for CMP slurry and other advanced semiconductor materials used for generative AI applications.
- In the Advanced Functional Materials business, revenue decreased by 7.0% year-over-year primarily due to the absence of large-scale data tape orders from IT companies that contributed in the previous year, as well as a decline in sales of display materials.
- Revenue increased by 3.8% year-over-year, reaching JPY298.6 billion, and operating income rose by 45.6% year-over-year, amounting to JPY15.8 billion.
- In the Business Solutions business, revenue growth was primarily driven by strong performance of solutions related to digital transformation and services provided to municipalities.
- The Office Solutions business saw a slight decrease in revenue due to the strategic streamlining of low-margin product sales for the Chinese market.
- In the Graphic Communications business, revenue increased, supported by higher sales of inkjet heads.
- Strong demand for instant photo systems and digital cameras drove revenue up by 15.6% year-over-year to JPY146.2 billion and operating income grew by 14.7% year-over-year to JPY38.6 billion.
- In the Consumer Imaging business, consistent demand for instax™ instant photo systems contributed to higher revenue.
- In the Professional Imaging business, revenue growth was supported by the strong performance of the X Series and GFX Series cameras.
For more details, please visit the Investor Relations section of Fujifilm website
FUJIFILM Holdings Corporation
Corporate Communications Division, Public Relations Group
- * Please note that the contents including the product availability, specification, prices and contacts in this website are current as of the date of the press announcement and may be subject to change without prior notice.